Skip to main navigation

Our Science
AT-527
COVID-19
About Atea
Investors
Careers
Contact

The tip of a pipette pointing towards droplets suspended in a green solution.

Investor Relations

Quarterly Reports

Breadcrumb

Investors
Quarterly Reports

Quarterly Reports

Show all

2023

Q2

Atea Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update
Second Quarter 2023 Financial Results Conference Call Presentation 3.1 MB
Second Quarter 2023 Financial Results Conference Call

Q1

Atea Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business Update
First Quarter 2023 Financial Results Conference Call Presentation 3.5 MB
First Quarter 2023 Financial Results Conference Call

2022

Q4

Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
Fourth Quarter 2022 Financial Results Conference Call Presentation 7.8 MB
Fourth Quarter 2022 Financial Results Conference Call
Form 10-K

Q3

Atea Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
Third Quarter 2022 Financial Results Conference Call Presentation 4.3 MB
Third Quarter 2022 Financial Results Conference Call
Form 10-Q

Q2

Atea Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
Second Quarter 2022 Financial Results Conference Call Presentation 4.2 MB
Second Quarter 2022 Financial Results Conference Call
Form 10-Q

Q1

Atea Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update
First Quarter 2022 Financial Results Conference Call Presentation 4.6 MB
First Quarter 2022 Financial Results Conference Call
Form 10-Q

2021

Q4

Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Fourth Quarter 2021 Financial Results Conference Call Presentation 3.9 MB
Fourth Quarter 2021 Financial Results Conference Call
Form 10-K

Q3

Atea Pharmaceuticals Provides Clinical and Corporate Update and Reports Third Quarter 2021 Financial Results
Third Quarter 2021 Financial Results Conference Call Presentation 2.7 MB
Third Quarter 2021 Financial Results Conference Call
Form 10-Q

Q2

Atea Pharmaceuticals Provides Clinical and Corporate Update and Reports Second Quarter 2021 Financial Results
Second Quarter 2021 Financial Results Conference Call Presentation 1.6 MB
Second Quarter 2021 Financial Results Conference Call
Form 10-Q

Q1

Atea Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
First Quarter 2021 Financial Results Conference Call
First Quarter 2021 Financial Results Conference Call Presentation 2.6 MB
Form 10-Q

2020

Q4

Atea Pharmaceuticals Reports Full Year 2020 Financial Results and Provides Corporate Update
Fourth Quarter and Full Year 2020 Financial Results Conference Call
Fourth Quarter and Full Year 2020 Financial Results Conference Call Presentation 6.8 MB
Form 10-K

Atea is a clinical-stage biopharmaceutical company working to address unmet medical needs through novel antiviral treatment.

Atea Pharmaceuticals, Inc.
225 Franklin Street
Suite 2100
Boston, MA 02110
(857) 284-8891

Copyright © 2023 By Atea Pharmaceuticals, Inc. All Rights Reserved. Privacy Policy | Terms of Use